Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 744

1.

[In Process Citation].

Kasper S.

World J Biol Psychiatry. 2015 Aug;16(5):279. doi: 10.3109/15622975.2015.1058585. No abstract available.

PMID:
26213110
2.

Activity of daptomycin- and vancomycin-loaded poly-epsilon-caprolactone microparticles against mature staphylococcal biofilms.

Ferreira IS, Bettencourt AF, Gonçalves LM, Kasper S, Bétrisey B, Kikhney J, Moter A, Trampuz A, Almeida AJ.

Int J Nanomedicine. 2015 Jul 7;10:4351-66. doi: 10.2147/IJN.S84108. eCollection 2015.

3.

Comparison of continuously acquired resting state and extracted analogues from active tasks.

Ganger S, Hahn A, Küblböck M, Kranz GS, Spies M, Vanicek T, Seiger R, Sladky R, Windischberger C, Kasper S, Lanzenberger R.

Hum Brain Mapp. 2015 Jul 15. doi: 10.1002/hbm.22897. [Epub ahead of print]

PMID:
26178250
4.

Increasing placebo response in antipsychotic trials: a clinical perspective.

Dold M, Kasper S.

Evid Based Ment Health. 2015 Aug;18(3):77-9. doi: 10.1136/eb-2015-102098. Epub 2015 Jun 29.

PMID:
26124311
5.
6.

Temperament and character profiles in bipolar I, bipolar II and major depressive disorder: Impact over illness course, comorbidity pattern and psychopathological features of depression.

Zaninotto L, Souery D, Calati R, Di Nicola M, Montgomery S, Kasper S, Zohar J, Mendlewicz J, Robert Cloninger C, Serretti A, Janiri L.

J Affect Disord. 2015 Sep 15;184:51-9. doi: 10.1016/j.jad.2015.05.036. Epub 2015 May 28.

PMID:
26070046
7.

Dose escalation of antipsychotic drugs in schizophrenia: A meta-analysis of randomized controlled trials.

Dold M, Fugger G, Aigner M, Lanzenberger R, Kasper S.

Schizophr Res. 2015 Aug;166(1-3):187-93. doi: 10.1016/j.schres.2015.04.024. Epub 2015 May 23.

PMID:
26008883
8.

Editorial.

Kasper S.

World J Biol Psychiatry. 2015 Jun;16(4):211. doi: 10.3109/15622975.2015.1037100. No abstract available.

PMID:
25986407
9.
10.

Dimensions of Delusions in Major Depression: Socio-demographic and Clinical Correlates in an Unipolar-Bipolar Sample.

Zaninotto L, Souery D, Calati R, Camardese G, Janiri L, Montgomery S, Kasper S, Zohar J, De Ronchi D, Mendlewicz J, Serretti A.

Clin Psychopharmacol Neurosci. 2015 Apr 30;13(1):48-52. doi: 10.9758/cpn.2015.13.1.48.

11.

Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: A comparison with other psychiatric disorders.

Bridler R, Häberle A, Müller ST, Cattapan K, Grohmann R, Toto S, Kasper S, Greil W.

Eur Neuropsychopharmacol. 2015 Jun;25(6):763-72. doi: 10.1016/j.euroneuro.2015.03.017. Epub 2015 Apr 11.

PMID:
25907249
12.

Ketamine-Induced Modulation of the Thalamo-Cortical Network in Healthy Volunteers As a Model for Schizophrenia.

Höflich A, Hahn A, Küblböck M, Kranz GS, Vanicek T, Windischberger C, Saria A, Kasper S, Winkler D, Lanzenberger R.

Int J Neuropsychopharmacol. 2015 Apr 19;18(9). pii: pyv040. doi: 10.1093/ijnp/pyv040.

13.

Neuronal cell adhesion genes and antidepressant response in three independent samples.

Fabbri C, Crisafulli C, Gurwitz D, Stingl J, Calati R, Albani D, Forloni G, Calabrò M, Martines R, Kasper S, Zohar J, Juven-Wetzler A, Souery D, Montgomery S, Mendlewicz J, Girolamo GD, Serretti A.

Pharmacogenomics J. 2015 Apr 7. doi: 10.1038/tpj.2015.15. [Epub ahead of print]

PMID:
25850031
14.

[In Process Citation].

Kasper S.

World J Biol Psychiatry. 2015 Apr;16(3):141. doi: 10.3109/15622975.2015.1014211. No abstract available.

PMID:
25822803
15.

Reduced default mode network suppression during a working memory task in remitted major depression.

Bartova L, Meyer BM, Diers K, Rabl U, Scharinger C, Popovic A, Pail G, Kalcher K, Boubela RN, Huemer J, Mandorfer D, Windischberger C, Sitte HH, Kasper S, Praschak-Rieder N, Moser E, Brocke B, Pezawas L.

J Psychiatr Res. 2015 May;64:9-18. doi: 10.1016/j.jpsychires.2015.02.025. Epub 2015 Mar 6.

16.

Voxel-based morphometry at ultra-high fields. a comparison of 7T and 3T MRI data.

Seiger R, Hahn A, Hummer A, Kranz GS, Ganger S, Küblböck M, Kraus C, Sladky R, Kasper S, Windischberger C, Lanzenberger R.

Neuroimage. 2015 Jun;113:207-16. doi: 10.1016/j.neuroimage.2015.03.019. Epub 2015 Mar 17.

PMID:
25791781
17.

The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression.

Kautzky A, Baldinger P, Souery D, Montgomery S, Mendlewicz J, Zohar J, Serretti A, Lanzenberger R, Kasper S.

Eur Neuropsychopharmacol. 2015 Apr;25(4):441-53. doi: 10.1016/j.euroneuro.2015.01.001. Epub 2015 Feb 2.

PMID:
25769916
18.

Second-Generation Antipsychotic Drugs in Anorexia Nervosa: A Meta-Analysis of Randomized Controlled Trials.

Dold M, Aigner M, Klabunde M, Treasure J, Kasper S.

Psychother Psychosom. 2015 Feb 21;84(2):110-116. [Epub ahead of print]

PMID:
25722106
19.

HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomas.

Reis H, Herold T, Ting S, Worm K, Huber U, Christoph DC, Eberhardt WE, Kostbade K, Kasper S, Stamatis G, Welter S, Darwiche K, Karpf-Wissel R, Theegarten D, Schmid KW, Schuler M, Wiesweg M.

Lung Cancer. 2015 Apr;88(1):34-41. doi: 10.1016/j.lungcan.2015.02.002. Epub 2015 Feb 7.

PMID:
25708529
20.

Updated version of the WFSBP guidelines for maintenance treatment of major depressive disorder.

Kasper S.

World J Biol Psychiatry. 2015 Feb;16(2):75. doi: 10.3109/15622975.2014.1002674. No abstract available.

PMID:
25677971
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk